1. Functional mechanism and clinical implications of miR-141 in human cancers.
- Author
-
Luo, Qi-qi, Tian, Yu, Qu, Guang-jin, Kun-Huang, and Luo, Shan-shun
- Subjects
- *
NON-coding RNA , *CANCER cell proliferation , *TUMOR markers , *DRUG therapy , *CELLULAR signal transduction , *KINASES , *CANCER cells , *CANCER cell migration - Abstract
Cancer is caused by the abnormal proliferation of local tissue cells under the control of many oncogenic factors. MicroRNAs (miRNAs) are a class of evolutionarily conserved, approximately 22-nucleotide noncoding small RNAs that influence transcriptional regulationby binding to the 3′-untranslated region of target messenger RNA. As a member of the miRNA family, miR-141 acts as a suppressor or an oncomiR in various cancers and regulates cancer cell proliferation, apoptosis, invasion, and metastasis through a variety of signaling pathways, such as phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) and constitutive activation of nuclear factor-κB (NF-κB). Target gene validation and pathway analysis have provided mechanistic insight into the role of this miRNA in different tissues. This review also outlines novel findings that suggest miR-141 may be useful as a noninvasive biomarker and as a therapeutic target in several cancers. • Regulatory mechanisms of miR-141 in cancer • Regulatory roles of miR-141 in various cancers • miR-141 as a tumor drug therapy • miR-141 as a drug resistance • miR-141 as a diagnostic marker of cancers [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF